Q&A

Let The Tech Transfer Work For You: Strategic Approaches On The Path To GMP Manufacture

GettyImages-2176475661 tabet press, pharma manufacturing

Tech transfer is often treated as a handoff, but in biomanufacturing, it is a crucial turning point. A process must establish that it can move beyond the laboratory, withstand scale up, and support the rigorous demands of GMP manufacture and regulatory approval. When rushed, gaps in data, process understanding, or control strategies can emerge at the most expensive stages of development. However, when approached strategically, tech transfer can establish the foundation for a successful process performance qualification (PPQ) and a smoother path to clinical and commercial manufacturing.

The most effective tech transfers do not simply move a process from one site to another; they use data, experimentation, and collaboration to ensure the process is ready for what comes next. In this Q&A, Rich Richieri, chief operations officer at Avid Bioservices, shares insights into the decisions that can make or break a tech transfer. Download the full article for guidance on evaluating process data, identifying critical process parameters, and navigating scale-up, comparability, contamination control, and more.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online